Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966276 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) (pTyr877) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized phosphopeptide derived from human HER2 around the phosphorylation site of tyrosine 877 (T-E-YP-H-A).
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pTyr877
- Vial size
- 100 μg
- Concentration
- 100ug/100ul.
- Storage
- -20°C
Submitted references More about: prognostic importance of low c-erbB2 expression in breast tumors.
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
Dittadi R, Gion M
Journal of the National Cancer Institute 2000 Sep 6;92(17):1443-4
Journal of the National Cancer Institute 2000 Sep 6;92(17):1443-4
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
Muthuswamy SK, Gilman M, Brugge JS
Molecular and cellular biology 1999 Oct;19(10):6845-57
Molecular and cellular biology 1999 Oct;19(10):6845-57
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI
Proceedings of the National Academy of Sciences of the United States of America 1994 Feb 15;91(4):1500-4
Proceedings of the National Academy of Sciences of the United States of America 1994 Feb 15;91(4):1500-4
No comments: Submit comment
No validations: Submit validation data